MCS-2

N/A

Report date: 2025/08/25 16:37:58
NME

Base Information

Drug NameMCS-2
Drug Alias NameBOTRESOMCS-2
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLower Urinary Tract SymptomsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHealth Ever Bio-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHealth Ever Bio-Tech Co Ltd
Active IndicationsN/A
Inactive IndicationsLower Urinary Tract SymptomsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A